Stručni rad

https://doi.org/10.57140/mj.53.2.3

Lipid profile of postmenopausal women

Dunja Šojat orcid.org/0000-0001-7269-3334 ; Sveučilište Josipa Jurja Strossmayera, Medicinski fakultet Osijek; Dom zdravlja Osječko-baranjske županije
Romana Marušić ; Sveučilište Josipa Jurja Strossmayera, Medicinski fakultet Osijek; Nacionalna memorijalna bolnica "Dr. Juraj Njavro" Vukovar
Klara Ormanac ; Klinički bolnički centar Osijek
Saška Marczi ; Sveučilište Josipa Jurja Strossmayera, Medicinski fakultet Osijek
Tatjana Bačun ; Sveučilište Josipa Jurja Strossmayera, Medicinski fakultet Osijek

Sažetak

Objectives: The main objectives of the research are to examine the incidence of hyperlipoproteinemia
in postmenopausal women and to determine the differences in lipid profile considering age, duration of
menopause and body mass index in postmenopausal women.
Respondents and methods: The research is structured as cross-sectional with historical data. The
research used data collected during regular check-ups in primary health care clinics in Osijek Health Center
from November 2021 to March 2022. Collected data: demographic data, information on the duration of
menopause, body mass, body height, body mass index, values of total, LDL, HDL cholesterol and
triglycerides, and data on associated diseases.
Results: 98 postmenopausal women were included in the research, of which over 50% had elevated
total and LDL cholesterol values, and 39.8% had elevated triglyceride values. Subjects aged 45 to 65 years
and subjects with a duration of menopause of 10 or more years had significantly higher values of total and
LDL cholesterol while no difference was observed in the lipid profile with regard to the body mass index.
Using the SCORE2 table, it was estimated that 65% of the subjects had a very high cardiovascular risk, and
only 6% of the subjects achieved the target values of LDL cholesterol in accordance with the cardiovascular
risk.
Conclusion: There is a very high incidence of hyperlipoproteinemia in postmenopausal women, and
the age and duration of menopause have an impact on the poorer achievement of the target values of the
lipid profile, while the body mass index showed no impact. Given the high prevalence of subjects with a
very high cardiovascular risk (SCORE 2 tables), intensive interventions are needed at all levels of health
care, especially at the primary level of health care, which include non-pharmacological and
pharmacological methods of treating hyperlipoproteinemia.

Ključne riječi

cardiovascular diseases; hyperlipoproteinemia; HMG-CoA reductase inhibitors; postmenopause

Hrčak ID:

307331

URI

https://hrcak.srce.hr/307331

Datum izdavanja:

21.8.2023.

Posjeta: 606 *